After more than a decade in which only one PrEP option — a daily pill — was available to prevent acquiring HIV, several new PrEP products are entering the scene. But a big test is ahead for these formulations: Will they be introduced in a way that is accessible, acceptable and affordable to those who need them most?
Continue Reading
MOSAIC is heading to Lima, Peru, for the HIV Research for Prevention Conference (HIVR4P 2024). We invite conference attendees to join us for the following sessions.
Continue Reading
Namibia’s government plans to introduce a new HIV prevention method—long-acting injectable cabotegravir, or CAB PrEP—this year. To prepare for CAB PrEP introduction, the Ministry of Health and Social Services, with support from the PEPFAR- and USAID-funded MOSAIC project, recently conducted a value chain situation analysis.
Continue Reading
MOSAIC’s youth-led, youth-focused webinar series was developed to be a safe space for young people to learn about HIV prevention methods that are in market or coming to market soon. Each session is led and facilitated by members of MOSAIC’s NextGen Squad, our team of youth advocates.
Continue Reading
MOSAIC is heading to Munich, Germany, for the International AIDS Conference (AIDS 2024). We invite conference attendees to join us for the following sessions.
Continue Reading
As the HIV prevention field continues to grow and introduce new HIV prevention methods such as the PrEP ring and CAB PrEP, individuals have more options to choose from. But having options alone does not equal having choice. To benefit from the availability of multiple PrEP options, PrEP users need to be able to make an informed choice.
Continue Reading
In this webinar, Ministry of Health leaders and partners from Zambia and Zimbabwe reflect on their early implementation experience and share critical learnings for other countries poised to introduce CAB PrEP this year.
Continue Reading
Last week, MOSAIC staff from Nigeria traveled to Cotonou, Benin, for the International Conference on HIV Treatment, Pathogenesis, and Prevention Research (INTEREST). They participated in the conference in person and, in this post, share their reflections.
Continue Reading
As the PrEP category expands to include new products, our marketing and demand generation efforts must communicate with young women about PrEP and product choice in their language so they are ultimately inspired to act. That’s why MOSAIC set out to build a strong, evidence-informed, unified brand for the category.
Continue Reading
When a country is poised to introduce a new biomedical prevention product, policymakers want to ensure that their rollout plan is based on the latest science and provides clear, standardized procedures for implementation. The WHO publishes global guidance on delivering new HIV prevention products, but those recommendations need to be adapted to the local context.
Continue Reading